FCA
RXDX

FinTrust Capital Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

FinTrust Capital Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13
Closed -$1.43K – 1363
2023
Q2 		$1.43K Hold
13
– – ﹤0.01% 1055
2023
Q1 		$1.43K Hold
13
– – ﹤0.01% 1051
2022
Q4 		$1.43K Sell
13
-84
-87% -$9.24K ﹤0.01% 1053
2022
Q3 		$5K Buy
+97
New +$5K ﹤0.01% 1027